CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer. Azur RAG, Olarte KCV, Ybanez WS, Ocampo AMM, et al. PLoS One 2024;19:e0300413.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Azur RAG, Olarte KCV, Ybanez WS, Ocampo AMM, et al. CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer. PLoS One 2024;19:e0300413.
PMID: 38739593